Ambev S.A. (ABEV3) - Total Liabilities
Based on the latest financial reports, Ambev S.A. (ABEV3) has total liabilities worth R$57.17 Billion BRL (≈ $11.22 Billion USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore ABEV3 cash generation efficiency to assess how effectively this company generates cash.
Ambev S.A. - Total Liabilities Trend (1997–2025)
This chart illustrates how Ambev S.A.'s total liabilities have evolved over time, based on quarterly financial data. Check ABEV3 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Ambev S.A. Competitors by Total Liabilities
The table below lists competitors of Ambev S.A. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Woodside Energy Group Ltd
AU:WDS
|
Australia | AU$26.68 Billion |
|
Edwards Lifesciences Corp
NYSE:EW
|
USA | $3.07 Billion |
|
MicroStrategy Incorporated
NASDAQ:MSTR
|
USA | $10.60 Billion |
|
Banco Bradesco DRC
BA:BBD
|
Argentina | AR$2.03 Trillion |
|
Banco Santander Brasil SA ADR
NYSE:BSBR
|
USA | $1.14 Trillion |
|
Rockwell Automation Inc
NYSE:ROK
|
USA | $7.43 Billion |
|
Datadog Inc
NASDAQ:DDOG
|
USA | $2.91 Billion |
|
Roche Holding AG
SW:RO
|
Switzerland | CHF62.82 Billion |
Liability Composition Analysis (1997–2025)
This chart breaks down Ambev S.A.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ABEV3 stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.96 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.24 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.65 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.39 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Ambev S.A.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Ambev S.A. (1997–2025)
The table below shows the annual total liabilities of Ambev S.A. from 1997 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | R$57.17 Billion ≈ $11.22 Billion |
-9.14% |
| 2024-12-31 | R$62.93 Billion ≈ $12.35 Billion |
+19.86% |
| 2023-12-31 | R$52.50 Billion ≈ $10.30 Billion |
-3.90% |
| 2022-12-31 | R$54.63 Billion ≈ $10.72 Billion |
+0.08% |
| 2021-12-31 | R$54.58 Billion ≈ $10.71 Billion |
+9.07% |
| 2020-12-31 | R$50.05 Billion ≈ $9.82 Billion |
+27.71% |
| 2019-12-31 | R$39.19 Billion ≈ $7.69 Billion |
+7.13% |
| 2018-12-31 | R$36.58 Billion ≈ $7.18 Billion |
-57.88% |
| 2017-12-31 | R$86.85 Billion ≈ $17.04 Billion |
+133.53% |
| 2016-12-31 | R$37.19 Billion ≈ $7.30 Billion |
-6.66% |
| 2015-12-31 | R$39.84 Billion ≈ $7.82 Billion |
+39.81% |
| 2014-12-31 | R$28.50 Billion ≈ $5.59 Billion |
+14.63% |
| 2013-12-31 | R$24.86 Billion ≈ $4.88 Billion |
+1.21% |
| 2012-12-31 | R$24.56 Billion ≈ $4.82 Billion |
+20.94% |
| 2011-12-31 | R$20.31 Billion ≈ $3.99 Billion |
+12.13% |
| 2010-12-31 | R$18.11 Billion ≈ $3.55 Billion |
+1.73% |
| 2009-12-31 | R$17.80 Billion ≈ $3.49 Billion |
-14.41% |
| 2008-12-31 | R$20.80 Billion ≈ $4.08 Billion |
+16.41% |
| 2007-12-31 | R$17.87 Billion ≈ $3.51 Billion |
+10.61% |
| 2006-12-31 | R$16.15 Billion ≈ $3.17 Billion |
+20.45% |
| 2005-12-31 | R$13.41 Billion ≈ $2.63 Billion |
-13.99% |
| 2004-12-31 | R$15.59 Billion ≈ $3.06 Billion |
+51.03% |
| 2003-12-31 | R$10.33 Billion ≈ $2.03 Billion |
+26.34% |
| 2002-12-31 | R$8.17 Billion ≈ $1.60 Billion |
+7.87% |
| 2001-12-31 | R$7.58 Billion ≈ $1.49 Billion |
+50.03% |
| 2000-12-31 | R$5.05 Billion ≈ $990.85 Million |
+34.24% |
| 1999-12-31 | R$3.76 Billion ≈ $738.13 Million |
+17.28% |
| 1998-12-31 | R$3.21 Billion ≈ $629.35 Million |
+6.54% |
| 1997-12-31 | R$3.01 Billion ≈ $590.72 Million |
-- |
About Ambev S.A.
Ambev S.A., through its subsidiaries, engages in the production, distribution, and sale of beer, draft beer, soft drinks, malt and food, and other beverages in Brazil, Central America and Caribbean, Latin America South, and Canada. The company offers beer, ready-to-drink cocktails and spritzers, soft drinks, water, teas, and isotonic drinks under the Brahma, Skol, Antarctica, Original, Quilmes, A… Read more